Galderma Group AG
Pan Facial Volume Restoration
- Conditions
- Volume Loss (Soft Tissue Ptosis or Atrophy )
- Interventions
- Device: Hyaluronic acid dermal filler gel
- First Posted Date
- 2012-03-06
- Last Posted Date
- 2023-03-01
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 60
- Registration Number
- NCT01545557
- Locations
- 🇧🇷
Galderma Investigational Center, Saö Paulo, Brazil
An Open, Uncontrolled Study of GK567 in the Deodorization of Malodorous Fungating Neoplastic Tumours
- Conditions
- Malodorous Infected Cutaneous Ulcer
- Interventions
- Drug: GK567
- First Posted Date
- 2012-03-01
- Last Posted Date
- 2014-02-06
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 21
- Registration Number
- NCT01541930
- Locations
- 🇯🇵
Galderma investigational site, Tokyo, Japan
Subjects' Satisfaction on Pan Facial Aesthetic Enhancement After Treatment With Azzalure® and the Restylane® Range
- Conditions
- Aging
- Interventions
- Drug: Botulinum Toxin Type A (Azzalure)Device: Restylane ranges
- First Posted Date
- 2012-02-08
- Last Posted Date
- 2021-02-18
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 60
- Registration Number
- NCT01529203
- Locations
- 🇬🇧
Galderma investigational site, Street, United Kingdom
Split-face Tolerability Comparison Between Adapalene-Benzoyl Peroxide Gel Versus Tretinoin Gel
- Conditions
- Acne Vulgaris
- Interventions
- First Posted Date
- 2012-01-31
- Last Posted Date
- 2022-08-01
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 73
- Registration Number
- NCT01522456
- Locations
- 🇺🇸
Stephens and Associates, Dallas, Texas, United States
Phase 3 Papulopustular Rosacea Study
- First Posted Date
- 2011-12-19
- Last Posted Date
- 2021-02-18
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 688
- Registration Number
- NCT01494467
- Locations
- 🇺🇸
Burke Pharmaceutical Research, Hot Springs, Arkansas, United States
🇨🇦Guildford Dermatology Specialists, Surrey, British Columbia, Canada
🇺🇸Total Skin and Beauty, Birmingham, Alabama, United States
CD5024 1% [Ivermectin 1%] Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study
- Conditions
- Papulopustular Rosacea
- Interventions
- First Posted Date
- 2011-12-16
- Last Posted Date
- 2015-10-28
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 962
- Registration Number
- NCT01493947
- Locations
- 🇨🇿
Galderma Invetigational site, Olomouc, Czech Republic
🇬🇧Galderma Investigational Site, Nuneaton, United Kingdom
Phase 3 Papulopustular Rosacea Study
- Conditions
- Papulopustular Rosacea (PPR)
- Interventions
- Drug: Azelaic acid 15% Gel
- First Posted Date
- 2011-12-16
- Last Posted Date
- 2021-02-18
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 683
- Registration Number
- NCT01493687
- Locations
- 🇺🇸
Dermatology Associates of Kingsport, PC, Kingsport, Tennessee, United States
🇨🇦Eastern Canada Cutaneous Research Associates, Halifax, Nova Scotia, Canada
🇺🇸UAB Dermatology Clinical Research, Birmingham, Alabama, United States
Intra-individual Comparison of Efficacy and Safety of Metvix® Natural Daylight Photodynamic Therapy Versus Conventional Metvix® Photodynamic Therapy in Subject With Mild Actinic Keratoses
- Conditions
- Actinic Keratoses
- Interventions
- First Posted Date
- 2011-11-21
- Last Posted Date
- 2021-02-18
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 100
- Registration Number
- NCT01475071
- Locations
- 🇦🇺
Galderma Investigational site, Carlton, Victoria, Australia
🇦🇺Galderma Investigational Site, Kogarah, New South Wales, Australia
Efficacy & Safety Comparison of Epiduo With Doxycycline Versus Vehicle With Isotretinoin in the Treatment of Severe Acne
- Conditions
- Acne
- Interventions
- First Posted Date
- 2011-11-18
- Last Posted Date
- 2021-02-18
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 266
- Registration Number
- NCT01474590
- Locations
- 🇨🇦
Galderma investigational site, Woodbridge, Canada
A Study of Treatment Preference During Cheek Contouring Comparing Restylane® SubQ With and Without the Addition of Lidocaine Hydrochloride
- Conditions
- Facial Tissue Augmentation
- Interventions
- Device: Restylane SubQDevice: Restylane SubQ Lidocaine
- First Posted Date
- 2011-09-12
- Last Posted Date
- 2022-09-22
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 54
- Registration Number
- NCT01431755
- Locations
- 🇸🇪
Plastikkirurggruppen, Stockholm, Sweden
🇸🇪ZMedical, Stockholm, Sweden
🇸🇪Akademikliniken, Stockholm, Sweden